Print this article

Pharmaceutical R&D goes East

FRANK U. FLOETHER
c/o Dr. Floether Consulting, Roemlistrasse 5, Amden, CH-8873, Switzerland

Abstract

The centre of global pharmaceutical industry is shifting.Offshoring of chemical & pharmaceutical R&D to Asia issteadily increasing. The article is addressing topics as:

  • reasons, drivers and necessity for Western Pharma togo East
  • importance and benefi ts of offshoring
  • intellectual property risks in Asia
  • cross-cultural aspects to consider when doingbusiness in Asia¬†

The importance of offshoring goes far beyond cost saving.Today it is about shortening cycle times, tapping into talentpools in India and China, penetrating new emerginghuge markets and developing products for local marketsin close proximity to customers. In summary, offshoring ofchemical and pharmaceutical R&D represents a powerfultool to cope with the current productivity challenges inmultinational pharma enterprises.